Pliant Therapeutics Files Q1 2025 10-Q
Ticker: PLRX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1746473
| Field | Detail |
|---|---|
| Company | Pliant Therapeutics, Inc. (PLRX) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Pliant Therapeutics filed its Q1 2025 10-Q. Financials updated.
AI Summary
Pliant Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operational activities. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This filing provides investors with an update on Pliant Therapeutics' financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks disclosed.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Quarterly financial reporting)
- 2025-01-01 — Reporting Period Start Date (Quarterly financial reporting)
Key Players & Entities
- PLIANT THERAPEUTICS, INC. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250508 (date) — Filing Date
- SOUTH SAN FRANCISCO (location) — Business Address City
- 650-481-6770 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 8, 2025.
What is the company's primary business address?
The company's business address is 331 Oyster Point Boulevard, South San Francisco, CA 94080.
What is the fiscal year end for Pliant Therapeutics, Inc.?
The fiscal year end for Pliant Therapeutics, Inc. is December 31.
What is the SIC code for Pliant Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Pliant Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding PLIANT THERAPEUTICS, INC. (PLRX).